psoriasis

Vine jungle rainforest
Biotech

Vyne’s psoriasis drug hit with FDA hold over testicular toxicity

The FDA slapped a clinical hold on a phase 1b plaque psoriasis trial after testicular toxicity was reported in dogs.
Nick Paul Taylor Apr 25, 2025 9:25am
pivot change turnaround direction walk away

Sanofi's oral TNF asset misses mark in phase 2 psoriasis trial

Apr 24, 2025 4:46am
scrabble tiles spelling out psoriasis

J&J, Protagonist's oral psoriasis prospect bests BMS' Sotyktu

Mar 10, 2025 7:30am
decision path change of plans arrows business decision

BMS backs out of Dupixent fight, axing asset despite phase 3 win

Feb 7, 2025 6:26am
Illustration connected puzzle pieces with the acronym MA

AbbVie acquires oral peptide biotech Nimble for $200M

Dec 13, 2024 10:38am
On target clinical trial success bullseye score

J&J, Protagonist's oral psoriasis prospect scores in phase 3s

Nov 19, 2024 11:44am